Sarcopenic obesity: Call to action and nutritional agenda from the international clinical nutrition community - PubMed

3 hours ago

Sarcopenic obesity (SO) is an obesity phenotype with low muscle mass and function, recognized as having significant negative clinical impacts.
The prevalence of SO is rising due to factors like sedentary lifestyles, obesity-related diseases causing muscle catabolism, and an aging population.
Structured obesity management, including medications, often leads to muscle mass loss, increasing SO risk.
An international network of clinical nutrition societies, including ESPEN, FELANPE, PENSA, SASPEN, and AuSPEN, declares SO a research and clinical priority.
The network promotes initiatives focusing on SO's nutritional implications, research, and the implementation of diagnosis and treatment in clinical practice.
Statements are provided on SO diagnosis using the SOGLI algorithm, its link to malnutrition, prevention through diet and nutrients, and nutrition-based strategies in obesity management.
Multimodal treatments combining optimal nutrition and exercise are emphasized for SO management.
A call to action is made for coordinated scientific, educational, and advocacy efforts to raise awareness and reduce SO's global morbidity and mortality burden.

Hasty Briefsbeta